We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Controversies Keep Janet Woodcock From Nomination as Commissioner, Panelists Say
Controversies Keep Janet Woodcock From Nomination as Commissioner, Panelists Say
Janet Woodcock has remained acting commissioner of the FDA since January rather than gaining a nomination for a permanent appointment because of a series of political difficulties, two prominent regulatory attorneys said yesterday in an FDAnews webinar.